文献

J-GLOBAL ID：201902202738938314   整理番号：19S1268540

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

著者 (19件)： Cristofanilli, Massimo (Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine) ,  Turner, Nicholas C (Institute of Cancer Research and Royal Marsden Hospital) ,  Bondarenko, Igor (Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4) ,  Ro, Jungsil (National Cancer Center) ,  Im, Seock-Ah (Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine) ,  Masuda, Norikazu (NHO Osaka National Hospital) ,  Colleoni, Marco (Istituto Europeo di Oncologia) ,  DeMichele, Angela (Center for Epidemiology and Biostatistics, University of Pennsylvania) ,  Loi, Sherene (Peter MacCallum Cancer Centre) ,  Verma, Sunil (Sunnybrook Odette Cancer Centre) ,  Verma, Sunil (Tom Baker Cancer Centre, University of Calgary) ,  Iwata, Hiroji (Aichi Cancer Center Hospital) ,  Harbeck, Nadia (Brustzentrum der Universität München (LMU)) ,  Zhang, Ke (Pfizer) ,  Jiang, Yuqiu (Pfizer) ,  Theall, Kathy Puyana (Pfizer) ,  Bartlett, Cynthia Huang (Pfizer) ,  Koehler, Maria (Pfizer) ,  Slamon, Dennis (University of California)
資料名： The Lancet Oncology
巻： 17  号： 4  ページ： 425-439  発行年： 2016年 
JST資料番号： SCOPUS  ISSN： 1470-2045  CODEN： LOANB 
発行国： イギリス (GBR)  言語： 英語 (EN)

タイトルに関連する用語 (1件)： Cancer